Trade ORKA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Oruka Therapeutics, Inc. (ORKA) is trading at US$79.50, down 0.85% today as of Oct 7, 16:00 EDT. The company has a market capitalisation of US$7.15B. Over the past 52 weeks, ORKA has traded between US$20.25 and US$115.52. On Syfe you can trade ORKA with $0 commission and add it to your watchlist.
| Previous close | US$80.18 |
|---|---|
| Market cap | US$7.15B |
| 52-week range | US$20.25 – US$115.52 |
| Volume | 809.89K |
| Exchange | US |
Oruka Therapeutics, Inc.
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Year: 2024
Oruka Therapeutics Names Chief Commercial Officer
Aug 24, 8:14 PM · MT Newswires
Oruka Therapeutics, Inc. (ORKA) stock is trading at US$79.50, -0.85% from the previous close of US$80.18.
The market cap for Oruka Therapeutics, Inc. (ORKA) stock is approximately US$7.15B.
The 52-week high for Oruka Therapeutics, Inc. (ORKA) stock is US$115.52.
The 52-week low for Oruka Therapeutics, Inc. (ORKA) stock is US$20.25.
Oruka Therapeutics, Inc. (ORKA) does not currently pay a dividend.
Stay on top of ORKA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
